In today’s world, some companies make poor quality medicines just to save money. In the long run, it is more expensive finding mistakes after they have been made than preventing them in the first place. Here GMP (Good Manufacturing Practice) is designed to ensure that mistakes do not occur. It is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product.
The main risks are: contamination of products unexpectedly, incorrect labels on containers, overdose or under dose of some active ingredients, resulting in ineffective treatment or adverse effects on health. GMP covers all aspects of production; from the starting materials, premises and equipment to the training and personal hygiene of staff. WHO has established detailed guidelines for good manufacturing practice. Many countries have formulated their own requirements for GMP based on WHO GMP. Others have harmonized their requirements, for example in the Association of South-East Asian Nations (ASEAN), in the European Union and through the Pharmaceutical Inspection Convention.
At DR BEST, we are following WHO-GMP guidelines to maintain the quality of drugs because making and distributing poor quality medicines leads to loss of credibility for everyone, both public and private health care and the manufacturer as well. On the other side implementation of GMP is an investment in good quality medicines. This will improve the health of the individual patient and the community, as well as benefiting the pharmaceutical industry and health professionals.